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Sexually dimorphic physiologic responses occur during fasting, hypoglycemia, and exer-
cise. The areas covered in this mini review include studies that have used isotopic tracer
methods and/or euglycemic clamp studies to investigate substrate metabolism during
the above common physiologic stress. Women have greater reliance on lipid metabolism
during fasting, hypoglycemia, and exercise while men exhibit preference of carbohydrate
utilization. Plasma glucose concentrations were shown to be lower, while free fatty acids
(FFA) and lipolysis higher in women compared to men after fasting. Hypoglycemia resulted
in significantly reduced epinephrine, norepinephrine, glucagon, growth hormone, pancre-
atic polypeptide, and hepatic glucose production responses in females as compared to
males. Sexual dimorphism during exercise was demonstrated by higher glycerol and FFA
responses in women compared to men and higher carbohydrate oxidation rate in men.
Mechanisms that can increase lipolytic rates in women include higher total fat mass,
enhanced lipolytic sensitivity to epinephrine, and increased activation of β adrenergic
receptors.
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Introduction
Physiologic responses to fasting, hypoglycemia, or exercise include activation of critical homeostatic
(counterregulatory) mechanisms to maintain or restore euglycemia. These mechanisms include a
series of autonomic nervous system (ANS), neuroendocrine and metabolic responses that increase
glucose availability by stimulating initially hepatic (later renal) glycogenolysis and gluconeogenesis
and enhanced lipolysis. Increased peripheral glycogenolysis provides three carbon precursors such
as lactate and pyruvate for gluconeogenesis. Lipolysis generates glycerol as another important
gluconeogenic substrate and free fatty acids (FFA) as energy that drives the process. Proteolysis
also produces substrates (amino acids) for the gluconeogenic process. Although these are general
responses in both sexes, there appears to be significant quantitative gender-based differences in
substrate utilization. Anumber of studies have demonstrated preference of carbohydratemetabolism
in men and lipid in women.
Understanding the sexual dimorphism present in fuel oxidation during different metabolic states
could contribute to the development of improved and specific gender-based nutritional guide-
lines such as during exercise programs. For individuals with diabetes, preventive and therapeutic
strategies modified for each gender could, potentially, assist in achieving and sustaining target
glycemia.
In this mini review, we will discuss sexual dimorphism in glucose and lipid metabolism during
different metabolic states while concentrating on in vivo mechanistic studies that have used
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isotopic tracer methods and/or hyperinsulinemic glucose clamp
studies to investigate gender-based differences in substrate
metabolism during fasting, hypoglycemia, or exercise.
Fasting
General responses to fasting are gender-neutral, and include
increases in plasma fatty acid and ketones, and a decrease in
plasma glucose concentrations (1). However, the decrement in
glucose and surge in lipids is significantly greater in women than
in men.
The gender-related differences start appearing even during
short-term calorie restriction and become prominent during pro-
longed fasting (2, 3). Mittendorfer et al. studied whole body lipid
and glucose kinetics during basal (14 h) and short-term (22 h)
fasting in healthy men and women matched for percent body fat
(3). Isotope labeled tracers of glucose ([2H2]glucose) and glycerol
([2H5]glycerol) were used tomeasure substrate kinetics. The study
demonstrated that women had a greater basal glycerol rate of
appearance (Ra), which is an index of whole body lipolytic rate
(women: 2.1 µmolkg bodywt 1min 1 vs. men: 1.5; p< 0.05).
Glucose kinetics (Ra and Rd) appeared to be similar between
the groups. Thus, metabolic changes during basal and short term
fasting involved a sexual dimorphism in lipid but not glucose
metabolism. Twomajor regulators of lipolysis: insulin (inhibition)
and epinephrine (stimulation) were suggested to be related to
the reported metabolic changes. Insulin was numerically lower in
women compared to men (women: 6 µU/ml vs. men: 9), while
epinephrine concentration during 14–22 h of fasting was signif-
icantly higher in men (women: 57 pg/ml vs. men: 23; p< 0.05).
Since there was no difference in glucose production between the
genders, the lower insulin concentration could suggest increased
hepatic insulin action in women compared to men under short-
term fasting conditions.
Greater gender-basedmetabolic differences were demonstrated
during more prolonged fasting (38–72 h) (4–7). Plasma glucose
concentrations were lower after 38 h of fasting (4) (women:
3.9mmol/l vs. men: 4.4; p= 0.02), while FFA (women: 1.3mmol/l
vs. men: 1; p< 0.02) and lipolysis (women: 259 µmol/kcal vs.
men: 194; p= 0.004) were higher in women compared to men.
About 72 h of fasting resulted in significantly higher plasma glyc-
erol levels in women (0.2mmol/l, p< 0.05) compared with men
(0.1mmol/l) (6). Merimee et al. (7) also investigated metabolic
changes during 72 h fast and reported that the plasma glucose level
fell to 66mg/dl in men and 48mg/dl in women (p< 0.01), and
the mean peak FFA concentration was 2.3mmol/l in women and
only 1.4mmol/l in men (p< 0.01). Gender-based differences in
FFA kinetics were demonstrated in 106 healthy subjects (8). The
study showed that total FFA Ra and FFA Ra with respect to fat-
free mass were greater in women than in men. This dimorphism
was explained by the differences in body composition between
genders (i.e., more body fat in women).
Possible explanations for the observed gender-based differ-
ences in lipid mobilization could include sexually dimorphic
changes in anatomic fat distribution (9). Men have a higher
distribution of visceral fat and women have greater lower body
and subcutaneous fat. Lower body fat has been demonstrated
to exhibit greater lipolytic rates resulting in higher plasma FFA
concentration compared to men (4, 10–12). Interestingly, visceral
adipose tissue is responsible for greater hepatic FFA delivery in
women than in men and the effect increases with increasing
visceral fat (13). Subcutaneous fat has a greater leptin expression
rate compared to visceral adipose tissue (14). Leptin is a “satiety
hormone” that regulates the amount of fat stored in the body and
women have been demonstrated to have two to three times higher
levels compared to men (14, 15). This has led to the speculation
that adipose tissue in women is somewhat resistant to leptin’s
lipogenic actions. However, two other studies, both by Jensen et al.
(16), demonstrated that the association between plasma leptin
concentration and percent body fat was similar in both genders.
Thus, the role of leptin sensitivity in men and women remains
unclear.
Several studies have reported improved insulin sensitivity
in women and suggested insulin’s role in sexually dimorphic
metabolic changes (17–22). However, in these studies, the influ-
ence of the menstrual cycle was either not considered or women
were studied during follicular phase when insulin sensitivity is
increased (23, 24). Many other studies showed no difference in
insulin sensitivity between genders (4, 25–31). Therefore, the
effects of insulin action on gender-specific metabolic changes
remain controversial.
Hypoglycemia
The hypoglycemic clamp technique produces a standardized
decrease in plasma glucose and stable glycemic plateau (32). Con-
trolling the rate of fall of plasma glucose or the period of hyperin-
sulinemic euglycemia immediately before inducing hypoglycemia
has been reported to affect the magnitude of neuroendocrine
responses during hypoglycemia. Additionally, the magnitude of
counterregulatory responses doubles for each 10mg/dl decrement
in plasma glucose below 70mg/dl.
We have previously investigated gender-related differences in
ANS, neuroendocrine andmetabolic counterregulatory responses
during hypoglycemia, and the physiologicmechanisms that deter-
mine those differences (33–37).We have reported that large sexual
dimorphisms exist in counterregulatory responses during both
a single episode of hypoglycemia and following repeated hypo-
glycemia (Figure 1). We have also described the role of CNS
drive in triggering gender differences in metabolic responses and
estrogen’s role in regulating ANS, neuroendocrine and metabolic
responses to hypoglycemia.
Gender-specific changes during a single-step 2-h hyperinsu-
linemic hypoglycemic clamp of 50mg/dl were investigated in
age and BMI matched males and females (34). Data obtained
during the steady-state period at the end of clamps demonstrated
significant sexual dimorphism in neuroendocrine and metabolic
responses to hypoglycemia. Epinephrine (women: 5.7 nM vs.
men: 8.8; p< 0.05), norepinephrine (women: 2.6 nM vs. men:
3.3; p< 0.05), glucagon (women: 127 ng/l vs. men: 215; p< 0.05),
growth hormone (women: 36 µg/l vs. men: 53; p< 0.05), pancre-
atic polypeptide (women: 144 pM vs. men: 291; p< 0.05), and
hepatic glucose production (women: 9.5 µmol/kg/min vs. men:
18.1; p< 0.05) responses were significantly reduced in females
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FIGURE 1 | Gender-based differences in glucose and lipid metabolism
during hypoglycemia " – increased, " " – significantly increased,
ANS – autonomic nervous system, HGP – hepatic glucose production,
FFA – free fatty acids.
compared to males. Diamond et al. (38) and Amiel et al. (39) have
also demonstrated similar sexual dimorphisms in neuroendocrine
counterregulatory responses during hypoglycemia in males and
females.
It was investigated whether gender-based differences in
metabolic changes observed in healthy subjects (described
above) also occur in individuals with type 1 diabetes (37). The
study demonstrated that women with type 1 diabetes (similar
to healthy women) had significantly reduced neuroendocrine
(growth hormone – women: 15 µg/l vs. men: 25; p< 0.05), ANS
(epinephrine – women: 2.6 nmol/l vs. men: 5; norepinephrine –
women: 1.7 nmol/l vs. men: 2.3; p< 0.05), endogenous glucose
production (women: 3.9 µmolkg 1min 1 vs. men: 9.4,
p< 0.01), and cardiovascular (mean arterial pressure – women:
75mmHg vs. men: 83; p< 0.01) responses to moderate hypo-
glycemia compared to men. The above study demonstrated that
significant neuroendocrine and metabolic sexual dimorphisms
exist in responses to hypoglycemia in individuals with type 1
diabetes.
In searching for the cause of sexually dimorphic counterregu-
latory responses during hypoglycemia, several mechanisms have
been proposed. One plausible explanation was that differences
in the neuroendocrine responses may have been due to differen-
tial glycemic thresholds. A glycemic threshold is defined as the
plasma glucose level at which counterregulatory hormones are
released. Thus, 15 lean healthy men and women were studied
during separate randomized single step hyperinsulinemic glucose
clamp studies at euglycemia (90mg/dl) or hypoglycemia of 70,
60, or 50mg/dl (33). The study demonstrated that the mag-
nitude of physiological counterregulatory responses that affect
glucose and lipid metabolism were reduced in healthy women
compared to men during each discreet level of hypoglycemia.
However, the cause of this dimorphism did not appear to be
differential glycemic thresholds as both sexes demonstrated sim-
ilar plasma glucose levels at which counterregulatory mecha-
nisms were activated (epinephrine, glucagon, growth hormone,
cortisol, and pancreatic polypeptide – 70–79mg/dl; muscle sym-
pathetic nerve activity – 60–69mg/dl; and norepinephrine –
50–59mg/dl). The finding that direct sympathetic nerve activity
as well as hypothalamo-pituitary responses were reduced during
hypoglycemia point to a reduced central nervous system efferent
response as a more likely mechanism for the sexually dimorphic
counterregulatory responses occurring during hypoglycemia.
Another plausible mechanism for gender-based differences in
substrate metabolism involves female reproductive hormones.
Estrogen has been demonstrated to reduce lipolysis and plasma
catecholamine concentration by either inhibiting secretion or
accelerating degradation (40, 41). To investigate estrogen’s role
in counterregulatory differences between genders during hypo-
glycemia, postmenopausal women on estrogen replacement were
compared with postmenopausal women who did not receive
replacement therapy and with age and BMI matched men dur-
ing a single episode of hypoglycemia (35). Postmenopausal
women on estrogen replacement were found to have reduced
(epinephrine, muscle sympathetic nerve activity, pancreatic
polypeptide, glucagon, endogenous glucose production, lactate,
and glycerol) counterregulatory responses to hypoglycemia as
compared to the similarly increased responses in women who
were not on the replacement therapy and men. Thus, estro-
gen appears to play a significant role in the gender-based
premenopausal differences in hypoglycemia-induced counterreg-
ulatory responses.
Interestingly, despite the above neuroendocrine and ANS
responses, glycerol was reported to be higher in females com-
pared to males during hypoglycemia (33, 34, 37). The differences
could be attributed to a greater glycerol turnover rate due to
increased peripheral fat accumulation and higher percent fat mass
in females. Another reasonable explanation is higher sensitivity
of the female adipose tissue to lipolytic hormones (epinephrine,
norepinephrine, growth hormone). In fact, women have been
shown to bemore sensitive to epinephrine-induced lipolysis com-
pared to men (42–44). Schmidt et al. investigated contribution of
specific adrenergic receptor(s) in mediating gender-related differ-
ences in metabolic responses (44). The study demonstrated that
infusion of epinephrine resulted in greater increases in glycerol,
FFA, and palmitate Ra and Rd per kilogram body weight in
women compared to men. Thus, in states of high epinephrine
concentrations (e.g., hypoglycemia), women would be predicted
to exhibit higher lipolysis and fat oxidation.
In addition to the gender-based differences during a single
bout of hypoglycemia, we have also investigated the impact
of antecedent hypoglycemia on subsequent counterregulatory
responses (36). Surprisingly, women appeared to bemore resistant
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to the blunting effects of repeated hypoglycemia on ANS, neu-
roendocrine and metabolic counterregulatory responses. In fact,
repeated hypoglycemia produced nearly twofold greater suppres-
sive effects on counterregulatory responses inmen as compared to
women. Thus, after two prior episodes of moderate hypoglycemia
(50mg/dl), the usual large sexual dimorphism in counterregula-
tory responseswas lost during a next day episode of hypoglycemia.
In other words, following day 1 hypoglycemia, counterregulatory
responses were equivalent during next day subsequent hypo-
glycemia. This finding may help explain the finding why intensive
glycemic control in younger women with type 1 diabetes results
in fewer episodes of severe hypoglycemia compared to men.
Exercise
A number of studies have investigated gender-based differences
in metabolic changes during differing exercise work intensities
(Figure 2).
Several studies from our own and other laboratories have
assessed gender differences during 90min of moderate-intensity
(50% VO2 max) cycle ergometer exercise (45, 46). The studies
demonstrated significantly higher glycerol and FFA responses in
women compared to men and higher carbohydrate oxidation
rate in men (45). Plasma FFA during exercise has been reported
to be produced from differing anatomical sites in women and
men (47–49). Roepstorff et al. demonstrated high myocellular
FIGURE 2 | Gender-based differences in glucose and lipid metabolism
during exercise. ", increased; "", significantly increased ANS autonomic
nervous system; HGP, hepatic glucose production; FFA, free fatty acids.
triacylglycerol degradation in women compared to negligible in
men during submaximal exercise. This was explained by higher
basal intramyocellular triacylglycerol in women compared with
men (48, 49). Steffensen et al. also reported similar results when
measuring myocellular triacylglycerol in 21 females and 21 males
during rest and exercise, and demonstrated 25% decrease in
myocellular triacylglycerol content in females during exercise and
no change in males (47).
Effects of long duration (2 h) exercise at 40% VO2max and
post exercise substrate metabolism were studied in 27 healthy
individuals (50). During exercise, women demonstrated higher fat
oxidation (51%, p< 0.02) compared withmen (44%). Men, on the
other hand, had significantly higher circulating catecholamines
and greater carbohydrate oxidation (53%, p< 0.01) than women
(46%). There were no differences between the genders in fuel
metabolism before or after (2 h recovery period) exercise.
Similar metabolic differences between genders were reported
in a study that investigated 7weeks of endurance training (51).
General adaptive changes to endurance training – decrease in
muscle carbohydrate utilization and increase in lipid oxidation
were present in both sexes; however, consistent with other
exercise studies, women utilized more lipid and men increased
carbohydrates during exercise. Thus duration and intensity of
the exercise did not change gender-based differences in substrate
metabolism during exercise.
To investigate the mechanisms for gender-specific responses
during exercise, healthy women during the follicular and luteal
phases of the menstrual cycle and healthy men were studied
during 90-min cycling exercise at 65% VO2max (52). [6,6-
2H]glucose was used to calculate glucose kinetics, which were
significantly different between women in each phase of the men-
strual cycle and between men and women. Women in the luteal
phase had lower glucose Ra (49 µmolkg 1min 1; p= 0.03),
Rd (49 µmolkg 1min 1; p= 0.03), and metabolic clearance
rate (10mlkg 1min 1; p= 0.04) at 90min of exercise com-
pared with women in follicular phase (52 µmolkg 1min 1,
52 µmolkg 1min 1, 9mlkg 1min 1, respectively). Women,
regardless of themenstrual cycle, had a lower respiratory exchange
ratio, glucose Ra and Rd, and metabolic clearance rate during
exercise compared with men (p< 0.05). During the study, muscle
biopsies were taken to investigate muscle glycogen utilization.
Women in the luteal phase had lower proglycogen (p= 0.04),
macroglycogen (p= 0.04), and total glycogen (p= 0.02) use dur-
ing exercise compared with women in follicular phase. Thus
female reproductive hormones appear to play an important role
in muscle sparing of glycogen utilization. Adding to this find-
ing, biopsy samples from skeletal muscle, heart, and liver in
estradiol treated rats demonstrated reduced glycogen metabolism
compared to non-treated male rats (53, 54).
The above studies clearly demonstrate that women have
reduced carbohydrate and increased lipid utilization compared to
men. The sexually dimorphic changes in ANS responses appear
to be a major contributor to these metabolic findings. Women
during exercise had significantly lower circulating epinephrine
and norepinephrine that are known to stimulate muscle
glycogenolysis and carbohydrate oxidation (45, 55, 56). Second,
the finding of increased lipid metabolism can be explained
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by sexually dimorphic stimulation of adrenergic receptors: while
both adrenoreceptors (α and β) are activated in men during exer-
cise, women have been shown to depend solely on β receptors (57,
58). Since α adrenoreceptors inhibit while β stimulate lipolysis,
this would result in net greater lipolysis in women (45).
Conclusion
Short-term fasting (14–22 h) resulted in sexually dimorphic
metabolic changes, which were more pronounced during
prolonged fasting (38–72 h): lipid metabolism was reported to
be higher and carbohydrate utilization lower in women compared
to men.
Neuroendocrine, ANS, and metabolic responses during hypo-
glycemia were nearly twofold greater in men compared to
age matched premenopausal women. Metabolic changes during
hypoglycemia were similar to fasting: women’s reliance on lipol-
ysis was higher and carbohydrates lower. Surprisingly, women
appeared to be resistant to the blunting effect of repeated hypo-
glycemia, which abolished the greater neuroendocrine and ANS
responses usually observed in men during hypoglycemia.
Autonomic nervous system responses were increased in men
relative towomen across a broad spectrumof submaximal exercise
intensities. Exercise intensity and duration as well as endurance
training also resulted in increased carbohydrate oxidation in men
but greater lipid utilization in women.
The mechanisms that trigger these differences could include:
(1) sexually dimorphic fat distribution, (2) estrogen’s effect
on circulating catecholamines, (3) gender-based differences in
epinephrine sensitivity, and (4) differences in CNS drive in
triggering gender-specific neuroendocrine, ANS, and metabolic
responses.
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